Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.

Naltrexone is not recommended during pregnancy. However, sustained-release naltrexone implant use in humans has resulted in cases of inadvertent foetal exposure. Here, we used clinically relevant dosing to examine the effects of maternally administered sustained-release naltrexone on the rat brain b...

Full description

Bibliographic Details
Main Authors: Waleed O Farid, Andrew J Lawrence, Elena V Krstew, Robert J Tait, Gary K Hulse, Sarah A Dunlop
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3530485?pdf=render
_version_ 1818965799555039232
author Waleed O Farid
Andrew J Lawrence
Elena V Krstew
Robert J Tait
Gary K Hulse
Sarah A Dunlop
author_facet Waleed O Farid
Andrew J Lawrence
Elena V Krstew
Robert J Tait
Gary K Hulse
Sarah A Dunlop
author_sort Waleed O Farid
collection DOAJ
description Naltrexone is not recommended during pregnancy. However, sustained-release naltrexone implant use in humans has resulted in cases of inadvertent foetal exposure. Here, we used clinically relevant dosing to examine the effects of maternally administered sustained-release naltrexone on the rat brain by examining offspring at birth and in adulthood. Maternal treatment (naltrexone or placebo implant) started before conception and ceased during gestation, birth or weaning. Morphometry was assessed in offspring at birth and adulthood. Adult offspring were evaluated for differences in locomotor behaviour (basal and morphine-induced, 10 mg/kg, s.c.) and opioid neurochemistry, propensity to self-administer morphine and cue-induced drug-seeking after abstinence. Blood analysis confirmed offspring exposure to naltrexone during gestation, birth and weaning. Naltrexone exposure increased litter size and reduced offspring birth-weight but did not alter brain morphometry. Compared to placebo, basal motor activity of naltrexone-exposed adult offspring was lower, yet they showed enhanced development of psychomotor sensitization to morphine. Developmental naltrexone exposure was associated with resistance to morphine-induced down-regulation of striatal preproenkephalin mRNA expression in adulthood. Adult offspring also exhibited greater operant responding for morphine and, in addition, cue-induced drug-seeking was enhanced. Collectively, these data show pronounced effects of developmental naltrexone exposure, some of which persist into adulthood, highlighting the need for follow up of humans that were exposed to naltrexone in utero.
first_indexed 2024-12-20T13:22:45Z
format Article
id doaj.art-ce2477fd5b7c4ad9a2eb3fa975e8116d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T13:22:45Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ce2477fd5b7c4ad9a2eb3fa975e8116d2022-12-21T19:39:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5281210.1371/journal.pone.0052812Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.Waleed O FaridAndrew J LawrenceElena V KrstewRobert J TaitGary K HulseSarah A DunlopNaltrexone is not recommended during pregnancy. However, sustained-release naltrexone implant use in humans has resulted in cases of inadvertent foetal exposure. Here, we used clinically relevant dosing to examine the effects of maternally administered sustained-release naltrexone on the rat brain by examining offspring at birth and in adulthood. Maternal treatment (naltrexone or placebo implant) started before conception and ceased during gestation, birth or weaning. Morphometry was assessed in offspring at birth and adulthood. Adult offspring were evaluated for differences in locomotor behaviour (basal and morphine-induced, 10 mg/kg, s.c.) and opioid neurochemistry, propensity to self-administer morphine and cue-induced drug-seeking after abstinence. Blood analysis confirmed offspring exposure to naltrexone during gestation, birth and weaning. Naltrexone exposure increased litter size and reduced offspring birth-weight but did not alter brain morphometry. Compared to placebo, basal motor activity of naltrexone-exposed adult offspring was lower, yet they showed enhanced development of psychomotor sensitization to morphine. Developmental naltrexone exposure was associated with resistance to morphine-induced down-regulation of striatal preproenkephalin mRNA expression in adulthood. Adult offspring also exhibited greater operant responding for morphine and, in addition, cue-induced drug-seeking was enhanced. Collectively, these data show pronounced effects of developmental naltrexone exposure, some of which persist into adulthood, highlighting the need for follow up of humans that were exposed to naltrexone in utero.http://europepmc.org/articles/PMC3530485?pdf=render
spellingShingle Waleed O Farid
Andrew J Lawrence
Elena V Krstew
Robert J Tait
Gary K Hulse
Sarah A Dunlop
Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.
PLoS ONE
title Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.
title_full Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.
title_fullStr Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.
title_full_unstemmed Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.
title_short Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.
title_sort maternally administered sustained release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood
url http://europepmc.org/articles/PMC3530485?pdf=render
work_keys_str_mv AT waleedofarid maternallyadministeredsustainedreleasenaltrexoneinratsaffectsoffspringneurochemistryandbehaviourinadulthood
AT andrewjlawrence maternallyadministeredsustainedreleasenaltrexoneinratsaffectsoffspringneurochemistryandbehaviourinadulthood
AT elenavkrstew maternallyadministeredsustainedreleasenaltrexoneinratsaffectsoffspringneurochemistryandbehaviourinadulthood
AT robertjtait maternallyadministeredsustainedreleasenaltrexoneinratsaffectsoffspringneurochemistryandbehaviourinadulthood
AT garykhulse maternallyadministeredsustainedreleasenaltrexoneinratsaffectsoffspringneurochemistryandbehaviourinadulthood
AT sarahadunlop maternallyadministeredsustainedreleasenaltrexoneinratsaffectsoffspringneurochemistryandbehaviourinadulthood